is a result of the herpes vaccine showing good result with HIV positive subjects taking the herpes vaccine. see below.
Most HIV-1-infected persons are also infected with HSV-1 and HSV-2, although HSV infections are often mild or asymptomatic. Symptomatic and asymptomatic HSV reactivations are common among HIV-1-infected persons and can be a cause of significant morbidity. Antiviral medications given for episodic outbreaks or as long-term suppressive treatment provide important clinical benefits to patients. Given the apparent epidemiologic synergy between HSV-2 and HIV-1, promoting awareness of HSV-2 treatment for the purpose of decreasing HIV-1 transmission and disease progression may have substantial public health benefits.